| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate |
2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a2b4b3650ee7d3208d24ebbe475dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8772adbbe9fa39d5ee440f88b3f24043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2558d314d5c6d35c0651d3dbdbb01e6a |
| publicationDate |
2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020139237-A3 |
| titleOfInvention |
A bilayer tablet formulation of atorvastatin calcium and ezetimibe |
| abstract |
The present invention relates to a pharmaceutical bilayer tablet formulation comprising atorvastatin calcium and ezetimibe. Further, the present invention provides a process that eliminates disadvantages of active agents. |
| priorityDate |
2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |